Eurasian Cancer Research Council - Company Profile

It is a healthcare private not for profit company based in Chembur, Maharashtra, India, established in 2017.
2017 Chembur, Maharashtra, India Active
Last Updated:
Access Report
About Eurasian Cancer Research Council

Eurasian Cancer Research Council, a active private not for profit company, was established on 21 July 2017 in Chembur, Maharashtra, India. Engaging in oncology clinics & cancer treatment within the hospital and medical care sector, it holds CIN: U85200MH2017NPL297682. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Vasave Ulhas Jayant (Director), Dilip Jiva Gavit (Director). Past directors included Somasundaram Subramanian. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Flat No. 10 Geetanjali 8Th Road, Near Diamod Garden, Chembur, Maharashtra, 400071.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U85200MH2017NPL297682

  • Registration Number

    297682

  • Incorporation Date

    21 July 2017

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 8 Year, 7 Months
  • Last Filing with ROC 31 Mar 2024
  • Revenue Growth **** 11.23%
  • Profit Growth **** -79.29%
  • Ebitda **** -141.98%
  • Net Worth -22.99%
  • Total Assets **** 15.09%
Company report

Eurasian Cancer Research Council

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Eurasian Cancer Research Council — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Eurasian Cancer Research Council?
Current Directors
Name Designation Appointment Date Status
Vasave Ulhas Jayant Director 21 Jul 2017 Current
Dilip Jiva Gavit Director 21 Jul 2017 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 08 Jun 2021 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Eurasian Cancer Research Council.

Eurasian Cancer Research Council, for the financial year ended 2023, experienced significant growth in revenue, with a 11.23% increase. The company also saw a substantial fall in profitability, with a 79.29% decrease in profit. The company's net worth observed a substantial decline by a decrease of 22.99%.

Eurasian Cancer Research Council revenue growth over time
Eurasian Cancer Research Council profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 11.23%
*******
*******
*******
*******
Revenue from Operations
*******
 11.21%
*******
*******
*******
*******
Total Assets
*******
 15.09%
*******
*******
*******
*******
Profit or Loss
*******
 -79.29%
*******
*******
*******
*******
Net Worth
*******
 -22.99%
*******
*******
*******
*******
EBITDA
*******
 -141.98%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Eurasian Cancer Research Council?

In 2023, Eurasian Cancer Research Council had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Eurasian Cancer Research Council?

Unlock and access historical data on people associated with Eurasian Cancer Research Council, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Eurasian Cancer Research Council, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eurasian Cancer Research Council's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Eurasian Cancer Research Council
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Eurasian Cancer Research Council last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.

  • Balance Sheet

    Eurasian Cancer Research Council has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.

  • Director Appointment

    Progress on Vasave Ulhas Jayant was appointed as a Director was appointed as a Director on 21 Jul 2017 & has been associated with this company since 8 years 7 months . was documented.

  • Director Appointment

    Progress on Dilip Jiva Gavit was appointed as a Director was appointed as a Director on 21 Jul 2017 & has been associated with this company since 8 years 7 months . was documented.

  • Company Incorporation

    The activity Eurasian Cancer Research Council was registered on 21 Jul 2017 with Roc Mumbai & aged 8 years 7 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Eurasian Cancer Research Council?

The CIN of Eurasian Cancer Research Council is U85200MH2017NPL297682.

Where is Eurasian Cancer Research Council headquartered?

Eurasian Cancer Research Council is headquartered at Flat No. 10 Geetanjali 8Th Road, Near Diamod Garden, Chembur, Maharashtra, 400071.

When was Eurasian Cancer Research Council incorporated?

Eurasian Cancer Research Council was incorporated on 21 July 2017.

Who are the current directors of Eurasian Cancer Research Council?

The current directors of Eurasian Cancer Research Council are

What is the primary industry of Eurasian Cancer Research Council?

The primary industry of Eurasian Cancer Research Council is Hospital And Medical Care.

Is Eurasian Cancer Research Council a listed company?

Eurasian Cancer Research Council is unlisted.

What is the capital structure of Eurasian Cancer Research Council?

The authorized capital of Eurasian Cancer Research Council is ₹0.10 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Eurasian Cancer Research Council?

The compliance status of Eurasian Cancer Research Council is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available